PhaseBio Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies for orphan diseases, with an initial focus on cardiopulmonary disorders, today announced that the first patient in a Phase 2b...
Initiation of Phase 1/2 Combination Clinical Trial with Evelo’s Monoclonal Microbial, EDP1503, and KEYTRUDA® (pembrolizumab) Across Various Indications Expected in First Half of 2019 Evelo Biosciences, Inc.. a clinical-stage biotechnology company developing monoclonal...
Certara®, the global leader in model-informed drug development, regulatory science, real-world evidence and market access, today announced the launch of version 2.3 of its Trial Simulator software to help drug developers improve clinical trial design, resulting in...
Multi-site clinical study brings together the best in class tumor-targeting imaging agent for brain cancer and the highest sensitivity NIR microscope-based detection device in late stage development Blaze Bioscience Inc., the Tumor Paint Company®, a biotechnology...
Tiziana Life Sciences plc (“Tiziana” or the “Company”) (Nasdaq: TLSA / AIM: TILS), a UK biotechnology company that focuses on the discovery and development of novel molecules to treat human disease in oncology and immunology, previously announced that it had submitted...
Email
Text